GEFITINIB-DERIVATE

Patent europeic · EP2242493 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2242493
Numer da la dumonda
EP09703515
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
22-01-2009
Publitgà
27-10-2010
Concedì
05-06-2013
Stritgà
31-01-2014
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 239/94 (2006.01)
A61P 35/00 (2006.01)
A61K 31/517 (2006.01)
A61K 31/535 (2006.01)
Prioritad
US 22806 22.01.2008
US 140073 22.12.2008
Dumonda PCT
PCT/US2009/000482 22.01.2009
Publicaziun PCT
WO2009/094216 30.07.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-08-2014

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.08.2014

  2. 05-06-2013

    Concedì

    Published in Swissreg on 05.06.2013

Partidas

Possessur

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Suite 500, Lexington, MA 02421, US

Inventur

TUNG, Roger

Lexington, MA 02421, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.